DK1064257T3 - Antitumormidler. - Google Patents
Antitumormidler.Info
- Publication number
- DK1064257T3 DK1064257T3 DK99909098T DK99909098T DK1064257T3 DK 1064257 T3 DK1064257 T3 DK 1064257T3 DK 99909098 T DK99909098 T DK 99909098T DK 99909098 T DK99909098 T DK 99909098T DK 1064257 T3 DK1064257 T3 DK 1064257T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- hydrogen
- antitumor agents
- benzensulphonyloxy
- alkynylimino
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000005277 alkyl imino group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- -1 benzensulphonyloxy Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9805868.8A GB9805868D0 (en) | 1998-03-20 | 1998-03-20 | Anti-tumour agents |
| PCT/GB1999/000786 WO1999048860A1 (en) | 1998-03-20 | 1999-03-16 | Anti-tumour agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1064257T3 true DK1064257T3 (da) | 2003-05-26 |
Family
ID=10828860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99909098T DK1064257T3 (da) | 1998-03-20 | 1999-03-16 | Antitumormidler. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6472435B1 (de) |
| EP (1) | EP1064257B1 (de) |
| JP (1) | JP2002507592A (de) |
| KR (1) | KR20010042056A (de) |
| CN (1) | CN1178900C (de) |
| AT (1) | ATE231836T1 (de) |
| AU (1) | AU746715B2 (de) |
| BR (1) | BR9908934A (de) |
| CA (1) | CA2319335A1 (de) |
| DE (1) | DE69905143T2 (de) |
| DK (1) | DK1064257T3 (de) |
| ES (1) | ES2192036T3 (de) |
| GB (1) | GB9805868D0 (de) |
| IL (1) | IL138590A (de) |
| NO (1) | NO20004663L (de) |
| NZ (1) | NZ506011A (de) |
| PT (1) | PT1064257E (de) |
| WO (1) | WO1999048860A1 (de) |
| ZA (1) | ZA200004386B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9805866D0 (en) | 1998-03-20 | 1998-05-13 | Zeneca Ltd | Anti-tumour agents |
| US6413533B1 (en) * | 1998-05-07 | 2002-07-02 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
| US20060099712A1 (en) * | 2004-11-08 | 2006-05-11 | Eastman Kodak Company | Correlation of anti-cancer activity of dyes with redox potentials |
| US7490453B2 (en) * | 2005-03-11 | 2009-02-17 | Medical Instill Technologies, Inc. | Sterile de-molding apparatus and method |
| US8501818B2 (en) * | 2005-03-14 | 2013-08-06 | Ceptaris Therapeutics, Inc. | Stabilized compositions of alkylating agents and methods of using same |
| US7872050B2 (en) | 2005-03-14 | 2011-01-18 | Yaupon Therapeutics Inc. | Stabilized compositions of volatile alkylating agents and methods of using thereof |
| US20110039943A1 (en) * | 2005-03-14 | 2011-02-17 | Robert Alonso | Methods for treating skin disorders with topical nitrogen mustard compositions |
| WO2009035566A1 (en) * | 2007-09-07 | 2009-03-19 | The Board Of Supervisors Of Louisianana State University And Agricultural And Mechanical College | Redox-gated liposomes |
| LT3494960T (lt) | 2008-03-27 | 2021-02-25 | Helsinn Healthcare Sa | Stabilizuotos alkilinimo agentų kompozicijos ir jų naudojimo būdai |
| KR101006166B1 (ko) * | 2008-12-10 | 2011-01-07 | 건국대학교 산학협력단 | 지하철 역 선로에 설치되는 자기성 분진 수거 장치 및 그 방법 |
| CA2837307C (en) | 2011-05-26 | 2020-08-04 | Indiana University Research And Technology Corporation | Quinone compounds for treating ape1 mediated diseases |
| WO2012167122A1 (en) | 2011-06-03 | 2012-12-06 | Indiana University Research And Technology Corporation | Compounds, compositions and methods for treating oxidative dna damage disorders |
| US10730903B2 (en) | 2016-09-19 | 2020-08-04 | Memorial Sloan-Kettering Cancer Center | Adenosine analogs as methyltransferase inhibitors for treating cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2862107D1 (en) * | 1977-12-02 | 1982-11-18 | Takeda Chemical Industries Ltd | Glucosamine-peptide derivatives and their pharmaceutical compositions |
| JPS58177934A (ja) | 1982-04-13 | 1983-10-18 | Takeda Chem Ind Ltd | ベンゾキノン誘導体 |
| NZ240785A (en) | 1991-11-28 | 1995-08-28 | Cancer Res Campaign Tech | Substituted nitro aniline derivatives and medicaments |
| GB9805866D0 (en) | 1998-03-20 | 1998-05-13 | Zeneca Ltd | Anti-tumour agents |
-
1998
- 1998-03-20 GB GBGB9805868.8A patent/GB9805868D0/en not_active Ceased
-
1999
- 1999-03-16 JP JP2000537845A patent/JP2002507592A/ja active Pending
- 1999-03-16 DK DK99909098T patent/DK1064257T3/da active
- 1999-03-16 IL IL13859099A patent/IL138590A/en not_active IP Right Cessation
- 1999-03-16 DE DE69905143T patent/DE69905143T2/de not_active Expired - Fee Related
- 1999-03-16 WO PCT/GB1999/000786 patent/WO1999048860A1/en not_active Application Discontinuation
- 1999-03-16 KR KR1020007010400A patent/KR20010042056A/ko not_active Application Discontinuation
- 1999-03-16 PT PT99909098T patent/PT1064257E/pt unknown
- 1999-03-16 AU AU28467/99A patent/AU746715B2/en not_active Ceased
- 1999-03-16 AT AT99909098T patent/ATE231836T1/de not_active IP Right Cessation
- 1999-03-16 NZ NZ506011A patent/NZ506011A/xx unknown
- 1999-03-16 US US09/646,464 patent/US6472435B1/en not_active Expired - Fee Related
- 1999-03-16 CN CNB998040908A patent/CN1178900C/zh not_active Expired - Fee Related
- 1999-03-16 EP EP99909098A patent/EP1064257B1/de not_active Expired - Lifetime
- 1999-03-16 ES ES99909098T patent/ES2192036T3/es not_active Expired - Lifetime
- 1999-03-16 CA CA002319335A patent/CA2319335A1/en not_active Abandoned
- 1999-03-16 BR BR9908934-3A patent/BR9908934A/pt not_active IP Right Cessation
-
2000
- 2000-08-24 ZA ZA200004386A patent/ZA200004386B/en unknown
- 2000-09-19 NO NO20004663A patent/NO20004663L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9908934A (pt) | 2005-10-25 |
| ATE231836T1 (de) | 2003-02-15 |
| EP1064257B1 (de) | 2003-01-29 |
| NZ506011A (en) | 2002-10-25 |
| NO20004663D0 (no) | 2000-09-19 |
| JP2002507592A (ja) | 2002-03-12 |
| CA2319335A1 (en) | 1999-09-30 |
| NO20004663L (no) | 2000-11-13 |
| CN1178900C (zh) | 2004-12-08 |
| ES2192036T3 (es) | 2003-09-16 |
| DE69905143T2 (de) | 2003-11-20 |
| PT1064257E (pt) | 2003-06-30 |
| DE69905143D1 (de) | 2003-03-06 |
| AU746715B2 (en) | 2002-05-02 |
| US6472435B1 (en) | 2002-10-29 |
| WO1999048860A1 (en) | 1999-09-30 |
| IL138590A (en) | 2004-08-31 |
| GB9805868D0 (en) | 1998-05-13 |
| AU2846799A (en) | 1999-10-18 |
| CN1293656A (zh) | 2001-05-02 |
| EP1064257A1 (de) | 2001-01-03 |
| ZA200004386B (en) | 2002-01-30 |
| KR20010042056A (ko) | 2001-05-25 |
| IL138590A0 (en) | 2001-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1064257T3 (da) | Antitumormidler. | |
| HUP0301690A2 (hu) | Szinergikus eljárások és készítmények rák kezelésére | |
| HK1068334A1 (en) | Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments | |
| HUP0102471A2 (hu) | 4-Benzil-piperidin alkilszulfoxid heterociklusok és használatuk altípus-szelektív NMDA antagonistaként és ezeket tartalmazó gyógyszerkészítmények | |
| DK1023308T3 (da) | Inhibitorer af nukleosidmetabolisme | |
| MXPA05009359A (es) | Tetrahidroisoquinolinas 2,5- y 2,6 substituidas para uso como moduladores 5-ht6. | |
| NZ334954A (en) | Substituted heterocycles as anti-tumor agents | |
| MY139612A (en) | Benzoxazine derivatives as 5-th6 modulators and uses thereof | |
| MY118004A (en) | Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents | |
| MY138466A (en) | Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
| MXPA05010651A (es) | Compuestos de pirazol. | |
| MXPA04000036A (es) | Benzofuranos sustituidos con (hetero) arilo como ligandos 5-ht. | |
| ES467069A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol | |
| BR9604907A (pt) | Derivados de nucleosideos hamocarbociclico de pirimidinodiona substituida aniviral e métodos de preparo dos mesmos e composiçoes contendo tais derivados como principios ativos | |
| PL335012A1 (en) | Novel derivatives of indan-1-ole, method of obtaining and composition containing them | |
| ES2190199T3 (es) | Agentes anti-tumorales. | |
| HUP0402544A2 (hu) | Kompozíció elektrolit oldathoz és eljárás az előállítására | |
| PT944618E (pt) | Novos compostos de n-benzenossulfonilo-1-prolina processo de preparacao e utilizacao em terapia | |
| WO2004110379A3 (en) | A1 adenosine receptor antagonists | |
| KR970706280A (ko) | 5-HT1A 길항제로서의 비사이클릭 카복스아미드(Bicyclic carboxamides as 5-HT1 antagonists) |